TIANE DAI, MD
Osteopathic Medicine at Normandie Ave, Torrance, CA
License number
California A114216
Category
Osteopathic Medicine
Type
Nephrology
Address
Address
21840 Normandie Ave, Torrance, CA 90502
Phone
(310) 222-5026
(310) 222-5027 (Fax)
(310) 222-5027 (Fax)
Professional information
Tiane Dai, Long Beach CA
Specialties:
Nephrologist
Address:
1050 Linden Ave, Long Beach, CA 90813
21840 Normandie Ave, Torrance, CA 90502
1000 W Carson St, Torrance, CA 90502
21840 Normandie Ave, Torrance, CA 90502
1000 W Carson St, Torrance, CA 90502
Use Of Hematopoietic Growth Factor Inducible Neurokinin-1 (Hgfin) As A Novel Biomarker
US Patent:
2013034, Dec 26, 2013
Filed:
Jun 10, 2013
Appl. No.:
13/914304
Inventors:
Tiane DAI - Torrance CA, US
Ying WANG - Torrance CA, US
Mukti PATEL-CHAMBERLIN - Torrance CA, US
Cynthia C. NAST - Rancho Palos Verdes CA, US
Janine LaPAGE - Redondo Beach CA, US
Nosratolah Dabir VAZIRI - Newport Beach CA, US
Madeleine V. PAHL - Orange CA, US
Ying WANG - Torrance CA, US
Mukti PATEL-CHAMBERLIN - Torrance CA, US
Cynthia C. NAST - Rancho Palos Verdes CA, US
Janine LaPAGE - Redondo Beach CA, US
Nosratolah Dabir VAZIRI - Newport Beach CA, US
Madeleine V. PAHL - Orange CA, US
International Classification:
G01N 33/68
US Classification:
435 724, 435 792, 436 87, 436501
Abstract:
The invention provides, in certain embodiments, a method of detecting an indicator of renal injury or renal disease. The method entails assaying a urine sample for hematopoietic growth factor inducible neurokinin-1 (HGFIN), wherein the presence of HGFIN at an elevated level indicates the presence and/or degree of renal injury or renal disease, and/or the rate of loss of renal function. In other embodiments, the invention provides a method of detecting an indicator of systemic inflammation. This method entails assaying a biological sample for HGFIN, wherein the presence of HGFIN at an elevated level indicates the presence and/or degree of systemic inflammation. Also provided, are methods of determining progression of these conditions, as well as methods of determining subjects' response to treatment.
Use Of Hematopoietic Growth Factor Inducible Neurokinin-1 (Hgfin) As A Novel Biomarker
US Patent:
2010017, Jul 8, 2010
Filed:
Nov 5, 2009
Appl. No.:
12/613385
Inventors:
Sharon Adler - Los Angeles CA, US
Tiane Dai - Torrance CA, US
Ying Wang - Torrance CA, US
Mukti Patel-Chamberlin - Torrance CA, US
Cynthia C. Nast - Rancho Palos Verdes CA, US
Janine LaPage - Redondo Beach CA, US
Madeleine V. Pahl - Orange CA, US
Tiane Dai - Torrance CA, US
Ying Wang - Torrance CA, US
Mukti Patel-Chamberlin - Torrance CA, US
Cynthia C. Nast - Rancho Palos Verdes CA, US
Janine LaPage - Redondo Beach CA, US
Madeleine V. Pahl - Orange CA, US
Assignee:
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center - Torrance CA
International Classification:
C12Q 1/34, G01N 33/50
US Classification:
435 18, 436 86
Abstract:
The invention provides, in certain embodiments, a method of detecting an indicator of renal injury or renal disease. The method entails assaying a urine sample for hematopoietic growth factor inducible neurokinin-1 (HGFIN), wherein the presence of HGFIN at an elevated level indicates the presence and/or degree of renal injury or renal disease, and/or the rate of loss of renal function. In other embodiments, the invention provides a method of detecting an indicator of systemic inflammation. This method entails assaying a biological sample for HGFIN, wherein the presence of HGFIN at an elevated level indicates the presence and/or degree of systemic inflammation. Also provided, are methods of determining progression of these conditions, as well as methods of determining subjects' response to treatment.
Treatment Of Peritoneal Injury Using Jak Inhibitors
US Patent:
2013030, Nov 14, 2013
Filed:
Mar 14, 2013
Appl. No.:
13/829163
Inventors:
Bancha SATIRAPOJ - Bangkok, TH
Ying WANG - Torrance CA, US
Cynthia C. NAST - Rancho Palos Verdes CA, US
Tiane DAI - Torrance CA, US
Ying WANG - Torrance CA, US
Cynthia C. NAST - Rancho Palos Verdes CA, US
Tiane DAI - Torrance CA, US
International Classification:
A61K 31/437
US Classification:
514287, 435 79, 435 612
Abstract:
The invention provides, in certain embodiments, a method of preventing and/or treating peritoneal injury and/or diminished function by administering an effective amount of one or more inhibitors of JAK. The invention also provides a pharmaceutical composition including a JAK inhibitor for the treatment of peritoneal injury and/or diminished function. In another aspect, the invention provides a method of detecting an indicator of peritoneal injury. The method entails assaying a biological sample for periostin, wherein the presence of periostin at an elevated level indicates the presence and/or degree of peritoneal injury. Also provided, are methods of identifying subject for treatment of peritoneal injury and/or diminished function, methods of determining progression of these conditions, as well as methods of determining subjects' response to treatment.